Torrent Pharmaceuticals Limited (TORNTPHARM) — FY25 Annual Report | 7 July 2025
Torrent Pharmaceuticals disclosed that shareholders with unregistered email addresses received a link to access the 52nd AGM notice and FY2024-25 integrated annual report via its website, urging email updates for future communications.
About Torrent Pharmaceuticals Limited (TORNTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when TORNTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track TORNTPHARM — Free💡 Ask AI about this filing
📊 More TORNTPHARM filings
- Announcement — 11 August 2026 Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August ...
- Announcement — 11 August 2026 Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company...
- 🔴 Financial Results — 4 August 2026 Torrent Pharmaceuticals announced a conference call transcript for Q1 FY26 results on August 4, 2026...
- 🟡 Board Meeting — 1 August 2026 Torrent Pharmaceuticals announced the cessation of Ameera Shah as an Independent Director effective ...
- 🔴 Financial Results — 30 July 2026 Torrent Pharmaceuticals announced that the audio recording of its conference call discussing financi...
🔥 Also filed on 7 July 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when TORNTPHARM files new disclosures
Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TORNTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research